Qing Zuraw, MD, MPH, MBA

RemeGen Biosciences
Wayne, PA, United States

Dr. Qing Zuraw is the Senior Vice President, Head of Global Clinical Development, Autoimmune Diseases at Remegen Biosciences. She received her medical degree from Cheeloo College of Medicine, Shandong University and master of public health degree from Johns Hopkin Bloomberg School of Public Health.

Presentation(s):

• L20: Telitacicept, a Human Recombinant Fusion Protein Targeting and Neutralizing B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (APRIL), in Rheumatoid Arthritis (RA) Patients with an Inadequate Response to Methotrexate (MTX): A Randomized, Double-Blind, Phase 3 Study

  Wednesday, November 15, 2023
  8:45 AM – 9:00 AM PT

  Disclosure information not submitted.